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death and duration of the disease were compared in familial 
patients from successive generations in the following groups: (1) 
All cases except from, 2009 (65); the data were also analyzed 
separately for Methionine/Methionine (M/M) and Methionine/
Valine /M/V) cases; (2) Generation age difference was compared 
in patients from 2009. Statistical evaluation was performed by 
Kaplan-Meier and Mann-Whitney tests.
In Group I the mean age at death was: 62.20 ± 7,219 y in 
the 1st and 50.04 ± 9.52 y in the 2nd generation. The difference 
of 12.16 y was signiﬁcant (p < 0.001). No signiﬁcant difference 
in the age at death between Met/Met and Met/Val patients was 
observed.
The mean duration was 5.75 ± 7.52 mo in the 1st and 4.41 
± 3.21months in the 2nd generation. The difference 1.34 was 
not signiﬁcant (p = 0.773). The difference of clinical duration 
between M/M and M/V cases in the 2nd generation 3.11 ± 1.84 
was at the border of signiﬁcance (p = 0.041). 
In Group II the mean age at death was 63.87 ± 6.54 y in 
the 1st and 48.96 ± 9.45 y in the 2nd generation. The difference 
14.91 ± 8.93 was signiﬁcant (p < 0.001).
Signiﬁcantly decreased mean age at death in patients from 
successive generation in Groups I and II conﬁrmed the anticipa-
tion in the analyzed gCJDE200K subtype and in Group II it 
conﬁrmed the suggested inﬂuence of anticipation on increased 
incidence of gCJD.3 The polymorphism M129V had no effect on 
the age at death, but it showed a slight (small number of heterozy-
gotes) inﬂuence upon the difference between the clinical duration 
in homo- and heterozygotes in the 2nd generation. Anticipation 
was described also in gCJDE200K in Israel.4 The evidence of 
anticipation in two most frequent subtypes of gCJDE200K sig-
nalizes that carriers of the E200K mutation in successive genera-
tions will develop the disease and die in decreasing, signiﬁcantly 
younger age. These data have not only prognostic value, but 
could be implemented in the prophylaxis. They also underline 
the importance of genetic testing in gCJD affected families.
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The European Food Safety Authority (EFSA) is the keystone of 
European Union (EU) risk assessment regarding food and feed 
safety. EFSA carries out independent scientiﬁc risk assessment in 
order to produce scientiﬁc opinions and advice for risk managers. 
The EFSA’s Scientiﬁc Panel on Biological Hazards (BIOHAZ) 
issues scientiﬁc opinions on biological hazards in relation to 
food safety and food-borne diseases including Transmissible 
Spongiform Encephalopathies.
Most of EFSA’s work in the TSE area is based on requests 
from the European Commission (EC), which are issued in the 
context of the strategic document The TSE Roadmap 2.1 This 
document underlines that any amendment to the EU measures 
on animal TSEs should maintain the EU’s high level of protec-
tion of human and animal health and of food safety and should 
be backed by solid science. Considering the current favorable 
evolution of the epidemic of Bovine Spongiform Encephalopathy 
(BSE) in the EU, the TSE Roadmap 2 outlines possible future 
changes to EU measures on BSE in the short, medium and long-
term until the year 2015. Moreover, measures on TSEs in small 
ruminants are also reﬂected upon in that strategy paper. Such 
possible changes would be related to: deﬁnition of Speciﬁed Risk 
Material, review of the current feed-ban, consideration of BSE 
monitoring schemes, measures on cohort-culling in bovine ani-
mals, consideration of ante-mortem and post-mortem rapid tests 
and review of Scrapie eradication measures.
The work describes the risk assessment activities undertaken 
by EFSA and its BIOHAZ Panel in the framework of the TSE 
Roadmap 2. In particular, the activities related to the revision of 
(1) the feed ban, (2) the BSE surveillance and (3) the Speciﬁed 
Risk Material are summarized and their impact on EU TSE pol-
icy outlined.
The scientiﬁc opinions of the EFSA BIOHAZ Panel will proof 
to be key to provide sound scientiﬁc basis to the risk managers in 
relaxing TSE controls in the EU without compromising the high 
level of consumer protection.
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Introduction. In the Netherlands an ambitious scrapie control 
program was started at the national level in 1998, based on 
genetic selection of animals for breeding. From 2002 onwards 
EU regulations required intensive active scrapie surveillance as 
well as certain control measures in affected ﬂocks.
Materials and Methods. Here we use standard statistical 
methods as well as mathematical modeling to analyze (1) data 
on genotype frequencies and scrapie prevalence in the Dutch 
sheep population obtained from both surveillance and affected 
ﬂocks; (2) data on PrP genotype frequencies in a random sample 
of ﬂocks; (3) postal survey results on between-ﬂock differences in 
breeding strategy and ﬂock management.
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Results and Conclusions. Analyzing the data (1) we ﬁnd that 
the breeding program has produced a steady increase in the level 
of genetic scrapie resistance in the Dutch sheep population. We 
also found that a few years later this was followed by a sharp 
decline in the prevalence of classical scrapie in tested animals. 
Notably, the estimated classical scrapie prevalence level per head 
of susceptible genotype declined signiﬁcantly as well. This indi-
cates that selective breeding has a disproportionate effect on 
infection prevalence, reminiscent of the well-known population 
effect of vaccination against a transmissible disease. The overall 
recent decline in classical scrapie prevalence in Dutch sheep sug-
gests that eradication of the disease in The Netherlands may be 
within reach. However, a subset of farms may still continue to 
act as a core group for scrapie transmission for some time, as we 
show by analyzing between-ﬂock heterogeneities using the data 
(2) and (3). In addition, genetic resistance levels may decline 
again in future as participation to the selective breeding program 
has recently become voluntary.
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Introduction. The trend of the BSE epidemic has been analyzed 
per country, using the active surveillance data from various EU 
countries.1 Now that the surveillance becomes less intensive, and 
the incidence declines below the detection limit, it is again inter-
esting to see whether we can predict the future behavior of the 
BSE prevalence.
Materials and Methods. We use a method previously devel-
oped to evaluate the impact of control measures for BSE2 and an 
age structured model to extrapolate the BSE prevalence into the 
future.3 Thus we can calculate the BSE prevalence using the his-
toric BSE surveillance data, under the assumption that the con-
trol measures remain the same, but also under various scenario’s 
with relaxed control measures.
Results. We ﬁnd that under the ﬁrst scenario (no change in 
control measures) classical BSE will probably not be found in 
the EU after 2020. If the control scenarios are relaxed, this does 
not change much, until the reproduction ratio of the infection 
increases above 1. If that is the case, the epidemic will return 
and slowly, the prevalence will again increase. Depending on the 
national situation different combinations of control measures can 
be considered sufﬁciently safe.
Conclusion. To eradicate BSE, continuation of the present 
control measures is effective. It may be more efﬁcient to apply 
a reduced set of control measures, but enforcing of such relaxed 
measures can be difﬁcult, depending on the national feed pro-
duction and animal husbandry situation.
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Background. The objective of the BSE monitoring in the Russian 
Federation (RF) is the conﬁrmation of the efﬁcacy of previously 
taken measures aimed at the reduction of BSE agent introduc-
tion and recirculation risk in cattle population. BSE monitoring 
is one of the activities of the Federal Service for Veterinary and 
Phytosanitary Surveillance (FSVPS) of the RF.
The most important measures of BSE control in Russia (in 
accordance with the OIE Questionnaire for BSE-status recog-
nition) are: (1) ‘feed ban’: prohibition on feeding of ruminant 
protein feeds to ruminants has been in effect in the RF since 
1990, control of ruminants’ feed production for absence of rumi-
nant components was introduced in 1996; laboratory control for 
ruminant genome was put in place in 2001; (2) restrictions on 
cattle and feed import from the countries where BSE cases were 
registered have been applied since 1989; (3) permanent notiﬁ-
cation program used when cattle showing BSE clinical signs is 
detected has been in place since 1999; (4) cattle identiﬁcation is 
performed at farm level at present; and (5) diagnostic tests of ani-
mals in the BSE risk groups, monitoring program in cattle have 
been in effect since 1999.
Material and Methods. BSE monitoring in 2011 was per-
formed in 23 RF regions where more than a thousand of bovine 
animals from controlled BSE risk countries had been imported. 
The population of adult (>24 mo) cattle in these regions is 3.51 
million animals or 38.9% of adult cattle population in the RF. 
Bio-Rad diagnostic kits and equipment were used for brain sam-
ple testing.
Results. 5,258 cattle brain samples were collected within 
monitoring program in 2011 that is 0.15% of adult cattle popu-
lation in RF regions participating in the monitoring program. 
More than 50% of samples were delivered from the largest 
livestock regions of Russia, such as Republics of Bashkortostan 
and Tatarstan, Krasnodar Territory, Rostov and Chelyabinsk 
Regions. Out of 5,258 submitted cattle brain samples 5,243 
(99.71%) samples were suitable for diagnostic testing (they con-
tained brain stem). The age of 90% of animals was 3–8 y. One 
brain sample was additionally tested using immunohistochem-
istry due to exceeding OD value detected by ELISA. In none of 
tested samples BSE agent was detected.
Conclusion. About 8,600 brain samples of cattle from risk 
groups predominantly were tested for BSE in the RF before 2011. 
